Home » hiv and aids » Recent Articles:

World AIDS Day: Shifting Policies in South Africa and the U.S.

December 2, 2009 Health News No Comments

The Health Blog normally ignores disease awareness days, weeks and months as pseudo-events designed to drum up media coverage. But a few nuggets pegged to this year’s World AIDS Day (today) seem noteworthy:

South Africa will provide free treatment for all HIV-positive infants under age 1 and expand treatment for others including HIV-positive pregnant women, President Jacob Zuma said. The announcement is significant not only because South Africa has the world’s largest population of HIV-positive people (5.7 million), but also because Zuma’s predecessor repeatedly denied that there was a link between HIV and AIDS. The U.S. said it would… Continue reading

UN Report: Data Shows Progress Needed On HIV Testing And Treatment For Children And Mothers

December 1, 2009 Health News No Comments

National efforts to combat AIDS, particularly by preventing mother-to-child transmission, are showing positive results, but many HIV and AIDS affected children still struggle to have their basic needs met, according to a report launched today by four United Nations agencies…

Go to Source… Continue reading

World Aids Day: Support Awareness with Products from Our Favorite Brands

December 1, 2009 Health News No Comments

World AIDS Day is December 1, and with new infections continuing to spread year after year, it is important to raise awareness. Understanding the facts is the key to fighting prejudice and protecting yourself and others when it comes to HIV and AIDS; learn more facts and stats at worldaidsday.org. Thankfully, some of our favorite designers have collaborated with Project RED to support, spread awareness and help make us look cool in the process.
Check out some of the most recent collaborations; plus, if you’re artistic or talented with a needle and thread, see how you can make… Continue reading

America wages new war in Vietnam — on AIDS

November 29, 2009 Health News No Comments

As memories of the eight-year war fade, the America that older Vietnamese remember, of bombers, guns and Agent Orange, is now represented to many by places such as Tinh Bien, where 340 HIV patients are getting treatment. Go to Source… Continue reading

Maternal HAART Minimizes The Risk Of Postnatal HIV Transmission

November 29, 2009 Health News No Comments

Researchers conducting clinical trials in Rwanda have concluded that the risk of postnatal transmission is minimal in HIV-positive mothers undergoing highly active antiretroviral therapy (HAART) while breastfeeding. The results of the trials have been published in the current issue of AIDS, the leading journal in the field of HIV and AIDS research.

Go to Source… Continue reading

Fighting HIV/AIDS globally

November 20, 2009 Health News No Comments

[/caption]

Eric Goosby, head of PEPFAR, on Wednesday reemphasized the U.S. commitment to fighting HIV/AIDS globally, the Associated Press reports. Despite concerns by international aid groups that the current economic climate might force HIV/AIDS funding to be scaled back, “Goosby said President Barack Obama and Secretary of State Hillary Rodham Clinton have assured him his program remains among ‘the highest priorities,’” the news service writes.

Goosby’s comments came during a telephone interview from Washington, where he “also described a new era of cooperation with South Africa, the nation that bears the greatest AIDS burden” and is also “the… Continue reading

Search This Site:

Content Tags:

brain breast cancer care cells children clinical data diabetes disease drug fda genetic h1n1 health health articles Health Care health topics heart hospital medical medicare mens health obama obesity patients phase protein reform researchers risk screening shows stroke study swine system therapy to treatment trial uk vaccine women women's health

ADS:

Featured Content:

New Genetic Test Helps Doctors Predict Frequency Of Genital Herpes Outbreaks

March 10, 2010

Molecular dermatology research and development innovator DermaGenoma, Inc. released The HerpesDX Genetic Test for Frequent Genital Herpes. The new screening test will help doctors assess patients’ risk for developing frequent Genital Herpes (HSV-2) outbreaks. “Until now, physicians have been unable to give patients an answer to the most common question asked by recently infected Genital Herpes patients: Will I have frequent outbreaks?,” says DermaGenoma CEO Andy Goren. “Using the HerpesDX genetic test, a doctor can finally assess a patient’s risk for frequent outbreaks…

Go to Source… Continue reading

New Genetic Test Helps Doctors Predict Frequency Of Genital Herpes Outbreaks

March 10, 2010

Molecular dermatology research and development innovator DermaGenoma, Inc. released The HerpesDX Genetic Test for Frequent Genital Herpes. The new screening test will help doctors assess patients’ risk for developing frequent Genital Herpes (HSV-2) outbreaks. “Until now, physicians have been unable to give patients an answer to the most common question asked by recently infected Genital Herpes patients: Will I have frequent outbreaks?,” says DermaGenoma CEO Andy Goren. “Using the HerpesDX genetic test, a doctor can finally assess a patient’s risk for frequent outbreaks…

Go to Source… Continue reading

Millennium Announces First Clinical Data For TAK-700 Prostate Molecule At ASCO GU

March 10, 2010

Millennium: The Takeda Oncology Company today announced the presentation of safety, pharmacokinetic and efficacy data from the Phase I portion of a Phase I/II clinical trial evaluating TAK-700 in patients with metastatic castration resistant prostate cancer (mCRPC). These data were presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU), held March 5-7, 2010 in San Francisco, CA…

Go to Source… Continue reading

ImmunoGen, Inc. Announces Orphan Drug Designation Granted To IMGN901 For Treatment Of Merkel Cell Carcinoma By US FDA And EU COMP

March 10, 2010

ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, announced that the US Food and Drug Administration (FDA) has granted orphan drug designation to its IMGN901 compound when used for the treatment of Merkel cell carcinoma (MCC). Through a separate process, the European Union (EU) Committee for Orphan Medicinal Products (COMP) concurrently also granted IMGN901 orphan medicinal product designation for the treatment of MCC…

Go to Source… Continue reading

BG Medicine And Abbott To Develop Galectin-3 Test For The I-STAT(R) System

March 10, 2010

BG Medicine, Inc. announced that it has entered into an agreement with Abbott Laboratories (NYSE: ABT) to extend its current development and commercialization collaboration to include the development of a galectin-3 test for Abbott Point of Care’s i-STAT® System. Galectin-3 is a novel biomarker that may play a role in detecting the development and progression of heart failure…

Go to Source… Continue reading

Refresher: What’s In The Health Reform Bills

March 10, 2010

Since the Senate passed its version of a health overhaul on Christmas Eve, most of the debate has focused on the politics of the effort. By now, many people have forgotten — if they ever knew — what the bill would actually do.

Related Audio

Morning Edition

So here’s a short refresher. According to the Congressional Budget Office, the Senate-passed bill would expand coverage to roughly 30 million of the 46 million people in the U.S. who lack health insurance. Most of the remaining uninsured would be undocumented immigrants, who would be ineligible for benefits… Continue reading

InterMune’s Lung Drug Gets Backing From FDA Panel

March 10, 2010

Another day, another stock-price jump.
First, the preliminaries: An advisory panel this afternoon recommended the FDA approve a lung drug developed by InterMune, with majorities of the outside experts saying the proposed treatment appeared effective and safe.
The FDA is expected to decide by early May whether to go along with the panel’s recommendation on pirfenidone, which is intended to treat patients with idiopathic pulmonary fibrosis. The FDA usually follows the lead of its advisory committees.
This all comes as good news for investors in InterMune, whose shares streaked nearly 60% higher Friday because the questions posed by the FDA staff for today’s… Continue reading

Vets Welcome Extension To UK Pet Travel Protection

March 10, 2010

The European Parliament has voted 618 votes to 17 for an extension to the transitional arrangements contained within the regulation on the non-commercial movement of pet animals (Reg. 998/2003) which afford the UK additional protection against rabies, ticks and tapeworms. The British Veterinary Association (BVA) and British Small Animal Veterinary Association (BSAVA) have been lobbying MEPs to support the extension and have strongly welcomed this decision…

Go to Source… Continue reading

Recent Comments:

  • JourneyHome: McCarran-Ferguson was originally designed to empower both the federal government and the individual states so that they could act to prevent insurance...
  • Hydro Closet: Hi, I thought I would say you have a wonderful site and rich content. I bookmarked your site and have it in my reader now...looking forward to future ...
  • Allan Ono: Getting more usage from drugs already approved by the FDA for new indications seems like a very good way to expand treatment options without the hyper...
  • Article Directory: Who can post an article in an article directory? Anyone who wishes to post an article can ...
  • Minh Terrebonne: Fantastic information in your blogpost, I watched this report on television yesterday about this same thing and since I am getting married next month ...

Popular Content: